Summary of Significant Accounting Policies (Details)				12 Months Ended
		Oct. 15, 2024 shares	May 16, 2023 $ / shares shares	Jun. 30, 2025 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) $ / shares
Summary of Significant Accounting Policies [Line Items]
Forward share split issued		100,000,000	25,000,000	100,000,000
Forward share split outstanding		100,000,000	25,000,000	100,000,000
Percentage split ratio		5:1	1-to-4
Common stock par value (in Dollars per share) | $ / shares	[1]			$ 0.001	$ 0.001
Tax position, description				A tax position is measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement.
Number of reportable segment				1
Finite-lived intangible assets (in Dollars) | $				$ 372,197	$ 391,016
Software [Member]
Summary of Significant Accounting Policies [Line Items]
Estimated useful lives				3 years
Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Estimated useful lives				6 years
Shanghai Sglcell Biotech Co., Ltd. [Member] | Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Finite-lived intangible assets (in Dollars) | $
Maximum [Member]
Summary of Significant Accounting Policies [Line Items]
Adjusted share split		5	4
Minimum [Member]
Summary of Significant Accounting Policies [Line Items]
Adjusted share split		1	1
IPO [Member]
Summary of Significant Accounting Policies [Line Items]
Capitalized deferred costs (in Dollars) | $					$ 638,871
Deferred initial public offering cost (in Dollars) | $
Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Forward share split issued		20,000,000
Forward share split outstanding		20,000,000
Common stock par value (in Dollars per share) | $ / shares			$ 0.001

[1] Giving retroactive effect to the 5 for 1 reverse share split effected on October 15, 2024.